Xenon to Announce Q2 2024 Financials on August 8, 2024

Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company traded on Nasdaq under the symbol XENE, is set to announce its financial and operating results for the second quarter of 2024. The announcement is scheduled for release after the closing of U.S. financial markets on Thursday, August 8, 2024. 

To discuss these results, Xenon Pharmaceuticals will hold a Conference Call and webcast on the same day. The call is scheduled for 4:30 pm Eastern Time (1:30 pm Pacific Time). Those interested in attending the webcast can pre-register through the provided link, while dial-in options are also available. For U.S. participants, a toll-free number (800) 715-9871 is provided, and for international callers, the number (646) 307-1963 can be used. The conference ID for the call is 1631616. The live audio webcast will be accessible from the Investors section of the Xenon website. Additionally, a replay of the webcast will be available approximately one hour after the event concludes and will remain on the website for about a month. 

Xenon Pharmaceuticals is dedicated to discovering, developing, and commercializing innovative therapies for patients suffering from neurological and psychiatric disorders. The company is advancing a novel product pipeline to address significant unmet medical needs, particularly in epilepsy and depression. Their leading product candidate, Azetukalner, is a Kv7 channel opener and is the most advanced and clinically validated potassium channel modulator currently in late-stage clinical development for various indications.

Xenon Pharmaceuticals operates with a mission to improve the lives of individuals affected by neurological and psychiatric conditions through groundbreaking treatments. The company’s commitment to innovation is reflected in its development programs and the potential impact of its therapies on patients' lives. 

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!